Squarepoint Ops LLC 9 Meters Biopharma, Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $2,785 - $6,856	10,713 New	10,713 $3,000
Q1 2022 May 16, 2022	SELL	$0.52 - $1.0 $6,552 - $12,600	-12,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.33 $497 - $778	-585 Reduced 4.44%	12,600 $12,000
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $10,379 - $14,208	-10,077 Reduced 43.32%	13,185 $17,000
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.5 $127,360 - $183,693	-122,462 Reduced 84.04%	23,262 $26,000
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $122,408 - $314,763	145,724 New	145,724 $170,000
Q4 2020 Feb 16, 2021	SELL	$0.65 - $1.11 $78,915 - $134,763	-121,409 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.48 - $0.84 $51,527 - $90,172	107,348 Added 763.44%	121,409 $99,000
Q2 2020 Aug 14, 2020	BUY	$0.43 - $0.74 $6,046 - $10,405	14,061 New	14,061 $8,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.